This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rangel, J. Articles by Kashani-Sabet, M. Search for Related Content PubMed PubMed Citation Articles by Rangel, J. Articles by Kashani-Sabet, M. Social Bookmarking                            What's this?

Prognostic Significance of Nuclear Receptor Coactivator-3 Overexpression in Primary Cutaneous Melanoma

Javier Rangel, Sima Torabian, Ladan Shaikh, Mehdi Nosrati, Frederick L. Baehner, Chris Haqq, Stanley P.L. Leong, James R. Miller, III, Richard W. Sagebiel, Mohammed Kashani-Sabet

From the Auerback Melanoma Research Laboratory, Cutaneous Oncology Program, University of California San Francisco Comprehensive Cancer Center; and the Departments of Dermatology, Pathology, Urology, and Surgery, University of California San Francisco, San Francisco, CA

Address reprint requests to Mohammed Kashani-Sabet, MD, University of California San Francisco Comprehensive Cancer Center, 1600 Divisadero St 2nd Fl, Box 1706, San Francisco, CA 94115; e-mail: kashanim{at}derm.ucsf.edu

PURPOSE: To assess the prognostic significance of nuclear receptor coactivator-3 (NCOA3) overexpression in primary cutaneous melanoma.

PATIENTS AND METHODS: NCOA3 expression was assessed using immunohistochemical analysis of a melanoma tissue microarray (TMA) containing primary melanomas from 343 patients with defined histology and follow-up. The impact of the presence or absence of various prognostic factors on relapse-free survival (RFS) and disease-specific survival (DSS) of melanoma patients was assessed using Cox regression and Kaplan-Meier analysis. The impact of presence or absence of various factors on sentinel lymph node (SLN) metastasis was assessed using logistic regression analysis.

RESULTS: Increasing degree of NCOA3 expression was significantly predictive of SLN metastasis (P = .013) and the mean number of SLN metastases (P = .031). Kaplan-Meier analysis demonstrated a significant association between NCOA3 overexpression and reduced RFS (P = .021) and DSS (P = .030). Logistic regression analysis revealed increasing degree of NCOA3 expression to be an independent predictor of SLN status (P = .017). Multivariate Cox regression analysis showed the independent impact of NCOA3 expression on RFS (P = .0095) and DSS (P = .021). NCOA3 was the most powerful factor predicting DSS, outperforming tumor thickness and ulceration.

CONCLUSION: These results identify NCOA3 as a novel, independent marker of melanoma outcome, with a significant impact on SLN metastasis, RFS, and DSS.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Kashani-Sabet, S. Venna, M. Nosrati, J. Rangel, A. Sucker, F. Egberts, F. L. Baehner, J. Simko, S. P.L. Leong, C. Haqq, et al. A Multimarker Prognostic Assay for Primary Cutaneous Melanoma Clin. Cancer Res., November 15, 2009; 15(22): 6987 - 6992. [Abstract] [Full Text] [PDF]

				H. Gogas, A. M. M. Eggermont, A. Hauschild, P. Hersey, P. Mohr, D. Schadendorf, A. Spatz, and R. Dummer Biomarkers in melanoma Ann. Onc., August 1, 2009; 20(suppl_6): vi8 - vi13. [Abstract] [Full Text] [PDF]

				B. E. G. Rothberg, M. B. Bracken, and D. L. Rimm Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis J Natl Cancer Inst, April 1, 2009; 101(7): 452 - 474. [Abstract] [Full Text] [PDF]

				D. Ornish, M. J. M. Magbanua, G. Weidner, V. Weinberg, C. Kemp, C. Green, M. D. Mattie, R. Marlin, J. Simko, K. Shinohara, et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention PNAS, June 17, 2008; 105(24): 8369 - 8374. [Abstract] [Full Text] [PDF]

				A. Miremadi, M. Z. Oestergaard, P. D.P. Pharoah, and C. Caldas Cancer genetics of epigenetic genes Hum. Mol. Genet., April 15, 2007; 16(R1): R28 - R49. [Abstract] [Full Text] [PDF]